For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital orga ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...

All-Star Victor Wembanyama won’t be able to finish the rest of the NBA season due to deep vein thrombosis. What is this ...

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.